Cite
HARVARD Citation
Hassan-Zahraee, M. et al. (2022). Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Inflammatory bowel diseases. 28 (3), pp. 434-446. [Online].